Losing 24 kilograms in a year and a half.
Eli Lilly
Posted inMetabolism, New Drugs, Regulatory
Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.
Posted inClinical Trials, Neuroscience
Buntanetap: Breakthrough in Treatment of Alzheimer’s and Parkinson’s
Buntanetap acts simultaneously on three neurotoxic proteins responsible for neurodegenerative disorders: amyloid beta, alpha-synuclein, and tau protein.
Posted inCOVID-19, Infections, Research
Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments
Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.
Posted inNeuroscience, New Drugs, Regulatory
Lybalvi: New Drug for Schizophrenia and Bipolar I Disorder
Combination of olanzapine and samidorphan will prevent unwanted weight gain in patients.
Posted inNeuroscience, New Drugs, Regulatory
Reyvow: Completely New Drug for Acute Treatment of Migraine
In the task of getting rid of headaches lasmiditan by Eli Lilly is as effective as the popular triptans, but safer.
Posted inClinical Trials, Neuroscience
Donanemab: Possible Treatment for Alzheimer’s Disease
The amyloid hypothesis, being verified by Eli Lilly, is not about to go away. However, the therapeutic achievements are still quite modest.